➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Merck
Moodys
Dow
McKesson

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Litigation Details for Avanir Pharmaceuticals Inc. v. Actavis South Atlantic LLC (D. Del. 2011)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Avanir Pharmaceuticals Inc. v. Actavis South Atlantic LLC
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Avanir Pharmaceuticals Inc. v. Actavis South Atlantic LLC (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
2012-10-17 12 disclosures related to U.S. Patent No. 8,227,484 (the '"484 patent") pursuant to Federal …products 1 and the asserted claim(s) of the '484 patent that Defendants 1 allegedly infringe by October…shall produce the file history for the '484 patent pursuant to paragraph 4.a of the £-Discovery…contentions for each asserted claim of the '484 patent, as well as the related invalidating references…references (e.g., publications, manuals, and patents) pursuant to paragraph 4.d of the £-Discovery External link to document
2012-10-26 187 ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (2) Avanir's Initial Claim Chart Relating…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (3) Avanir's Initial Claim Chart Relating…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (4) Avanir's Initial Claim Chart Relating…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; and (5) Avanir's Initial Claim Chart Relating…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484 by Avanir Pharmaceuticals Inc..(Noreika, External link to document
2012-10-30 189 ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (2) Avanir's Amended Initial Claim Chart…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (3) Avanir's Amended Initial Claim Chart…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (4) Avanir's Amended Initial Claim Chart…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; and (5) Avanir's Amended Initial Claim …ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484 by Avanir Holding Company, Avanir Pharmaceuticals External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Boehringer Ingelheim
McKesson
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.